Brown, Lisle/Cummings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.91K | Hold |
325
| – | – | ﹤0.01% | 525 |
|
|
2025
Q1 | $6.75K | Sell |
325
-75
| -19% | -$1.56K | ﹤0.01% | 532 |
|
|
2024
Q4 | $9.42K | Buy |
400
+21
| +6% | +$494 | ﹤0.01% | 489 |
|
|
2024
Q3 | $9.7K | Hold |
379
| – | – | ﹤0.01% | 470 |
|
|
2024
Q2 | $8.9K | Buy |
379
+129
| +52% | +$3.03K | ﹤0.01% | 466 |
|
|
2024
Q1 | $7.19K | Hold |
250
| – | – | ﹤0.01% | 461 |
|
|
2023
Q4 | $8.2K | Hold |
250
| – | – | ﹤0.01% | 458 |
|
|
2023
Q3 | $6.97K | Hold |
250
| – | – | ﹤0.01% | 444 |
|
|
2023
Q2 | $8.52K | Hold |
250
| – | – | ﹤0.01% | 432 |
|
|
2023
Q1 | $7.52K | Buy |
250
+75
| +43% | +$2.26K | ﹤0.01% | 428 |
|
|
2022
Q4 | $4.94K | Buy |
175
+75
| +75% | +$2.12K | ﹤0.01% | 442 |
|
|
2022
Q3 | $3.29K | Hold |
100
| – | – | ﹤0.01% | 450 |
|
|
2022
Q2 | $3.15K | Hold |
100
| – | – | ﹤0.01% | 433 |
|
|
2022
Q1 | $4.59K | Buy |
+100
| New | +$4.59K | ﹤0.01% | 433 |
|